Sign up to access historical data
Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$4.6M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$254M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Bala Mohan | Oct 28, 2024 | Sell | 1,884 | $1.9 | $3,600 |
| DeSchuytner Brian | Oct 3, 2024 | Sell | 5,598 | $1.96 | $11,000 |
| Carvajal Alejandra | Oct 3, 2024 | Sell | 5,598 | $1.96 | $11,000 |
| Bala Mohan | Oct 3, 2024 | Sell | 5,598 | $1.96 | $11,000 |
| Mandelia Ashish | Oct 3, 2024 | Sell | 3,361 | $1.96 | $6,600 |
| Lowinger Timothy B | Oct 3, 2024 | Sell | 5,598 | $1.96 | $11,000 |
| DeSchuytner Brian | Oct 2, 2024 | Sell | 8,089 | $2 | $16,000 |
| Carvajal Alejandra | Oct 2, 2024 | Sell | 8,089 | $2 | $16,000 |
| Bala Mohan | Oct 2, 2024 | Sell | 8,089 | $2 | $16,000 |
| Mandelia Ashish | Oct 2, 2024 | Sell | 4,855 | $2 | $9,700 |
| Lowinger Timothy B | Oct 2, 2024 | Sell | 8,089 | $2 | $16,000 |
| Huber Martin H. Jr. | Sep 12, 2024 | Sell | 50,423 | $1.76 | $89,000 |
| Protopapas Anna | Jan 16, 2024 | Sell | 29,399 | $2.71 | $80,000 |
| Lowinger Timothy B | Jan 16, 2024 | Sell | 10,409 | $2.71 | $28,000 |
| MISRA TUSHAR | Jan 16, 2024 | Sell | 3,357 | $2.71 | $9,100 |
| Mandelia Ashish | Jan 16, 2024 | Sell | 5,025 | $2.71 | $14,000 |
| Carvajal Alejandra | Jan 16, 2024 | Sell | 4,381 | $2.71 | $12,000 |
| DeSchuytner Brian | Jan 16, 2024 | Sell | 9,327 | $2.71 | $25,000 |
| Bala Mohan | Jan 16, 2024 | Sell | 3,431 | $2.71 | $9,300 |
| Bala Mohan | Oct 26, 2023 | Sell | 1,912 | $1.13 | $2,200 |
| MISRA TUSHAR | Aug 17, 2023 | Sell | 1,908 | $1.18 | $2,300 |
| Carvajal Alejandra | Apr 27, 2023 | Sell | 3,944 | $3.89 | $15,000 |
| Protopapas Anna | Jan 17, 2023 | Sell | 17,346 | $5.74 | $100,000 |
| Yang Arvin | Jan 17, 2023 | Sell | 2,209 | $5.74 | $13,000 |
| Mandelia Ashish | Jan 17, 2023 | Sell | 3,575 | $5.74 | $21,000 |
| Lowinger Timothy B | Jan 17, 2023 | Sell | 6,233 | $5.74 | $36,000 |
| DeSchuytner Brian | Jan 17, 2023 | Sell | 5,131 | $5.74 | $29,000 |
| MISRA TUSHAR | Jan 17, 2023 | Sell | 458 | $5.74 | $2,600 |
| Carvajal Alejandra | Jan 17, 2023 | Sell | 782 | $5.74 | $4,500 |
What's the latest insider transaction for Mersana Therapeutics?
The most recent insider transaction for Mersana Therapeutics was conducted by Bala Mohan, who sold 1,884 shares on October 28, 2024 at a price of $1.90 per share.
Which insider has sold the most MRSN stock over the last two years?
Protopapas Anna has sold the most MRSN stock in the last 2 years, with a total value of $180,000.
What is the total value of insider transactions for Mersana Therapeutics (MRSN) in the last 2 years?
The total value of insider transactions for Mersana Therapeutics in the last 2 years is negative, amounting to -$620,000. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Mersana Therapeutics' market confidence?
Over the last 2 years, insider transactions for Mersana Therapeutics have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
